Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Praxis Precision Medicines, Inc.PRAX · Entity 3538 | Chief Financial Officer | May 14, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Praxis Precision Medicines, Inc.
Report date May 14, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,167 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 121 · Balance 31,167 F1: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 20, 2026 01:44 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 121 | $167.94 | $20,321.10 |
DisclosureSEC source: 0001689548-26-000050 · wk-form4_1779241477.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,167 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 01:18 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 943 | $275.74 | $260,022.82 |
DisclosureSEC source: 0001863297-26-000005 · wk-form4_1768353511.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,046 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 10, 2026 Filed Jan 12, 2026 22:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 1,335 | $288.45 | $385,080.75 |
DisclosureSEC source: 0001689548-26-000011 · wk-form4_1768258139.xml · nonDerivative · entry 2 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,989 F2 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 7,040 | $0.00 Strike: $294.38 | $0.00 |
DisclosureSEC source: 0001689548-26-000011 · wk-form4_1768258139.xml · derivative · entry 3 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,040 Underlying: Common Stock · 7,040 shares Expires 2036-01-08 F3 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 8,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-26-000011 · wk-form4_1768258139.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,324 F1 · kind: Mr. Kelly was awarded 8,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:47 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 139 | $292.63 | $40,675.57 |
DisclosureSEC source: 0001863297-26-000002 · wk-form4_1767995220.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,524 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| November 14, 2025 Filed Nov 22, 2025 02:42 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 384 | $31.62 | $12,142.08 |
DisclosureSEC source: 0001104659-25-115100 · tm2531977-3_4seq1.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,663 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 14, 2025 Filed May 19, 2025 20:55 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 249 | $31.54 | $7,852.22 |
DisclosureSEC source: 0001689548-25-000065 · wk-form4_1747688130.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,279 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 12, 2025 Filed Jan 14, 2025 23:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 676 | $63.15 | $42,689.40 |
DisclosureSEC source: 0001689548-25-000014 · wk-form4_1736898639.xml · nonDerivative · entry 2 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,030 F2 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 23:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $63.15 | $0.00 |
DisclosureSEC source: 0001689548-25-000014 · wk-form4_1736898639.xml · derivative · entry 3 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-01-10 F3 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 23:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-25-000014 · wk-form4_1736898639.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,706 F1 · shares: Mr. Kelly was awarded 12,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2025 Filed Jan 9, 2025 00:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 139 | $77.52 | $10,775.28 |
DisclosureSEC source: 0001689548-25-000005 · wk-form4_1736383793.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,206 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| November 14, 2024 Filed Nov 20, 2024 02:48 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 205 | $37.40 | $7,667.00 |
DisclosureSEC source: 0001104659-24-120746 · tm2428929-1_4seq1.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,345 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:00 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 36,400 | $0.00 Strike: $56.94 | $0.00 |
DisclosureSEC source: 0001104659-24-084502 · tm2420554-1_4seq1.xml · derivative · entry 2 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,400 Underlying: Common Stock · 36,400 shares Expires 2034-07-29 F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:00 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-084502 · tm2420554-1_4seq1.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,140 F1 · shares: Mr. Kelly was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date. Read SEC document |
| May 14, 2024 Filed May 20, 2024 12:10 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 606 | $12.37 | $7,495.01 |
DisclosureSEC source: 0001689548-24-000064 · wk-form4_1716207028.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,340 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001689548-24-000021 · wk-form4_1705528288.xml · derivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the "Grant Date") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2024 Filed Jan 10, 2024 02:11 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 139 | $25.19 | $3,501.41 |
DisclosureSEC source: 0001689548-24-000008 · wk-form4_1704852697.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,734 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| May 12, 2023 Filed May 19, 2023 01:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 11,683 | $0.88 | $10,327.77 |
DisclosureSEC source: 0001689548-23-000092 · wf-form4_168446094488318.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,099 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 17:10 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | PurchaseCommon Stock | 8,000 | $0.87 | $6,997.60 |
DisclosureSEC source: 0001104659-23-037021 · tm2310645-1_4seq1.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,416 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.861 to $0.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| March 24, 2023 Filed Apr 6, 2023 21:43 UTC Amendment | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | PurchaseCommon Stock | 8,000 | $0.87 | $6,997.60 |
DisclosureSEC source: 0001104659-23-042818 · tm2312024-1_4aseq1.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,416 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.861 to $0.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 12:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 42,455 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000018 · wf-form4_167361412920494.xml · derivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,455 Underlying: Common Stock · 42,455 shares Expires 2033-01-12 F1 · shares: Mr. Kelly opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022. Read SEC document |
| January 12, 2023 Filed Jan 18, 2023 00:40 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000028 · wf-form4_167400240523604.xml · derivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 23:14 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 2,079 | $2.52 | $5,239.08 |
DisclosureSEC source: 0001689548-23-000005 · wf-form4_167330608086940.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,416 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| November 14, 2022 Filed Nov 21, 2022 11:04 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 5 | $1.81 | $9.06 |
DisclosureSEC source: 0001689548-22-000129 · wf-form4_166902868003160.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,495 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:46 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000090 · wf-form4_165610354831826.xml · derivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:51 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | PurchaseCommon Stock | 10,000 | $1.77 | $17,650.00 |
DisclosureSEC source: 0001689548-22-000078 · wf-form4_165515344848704.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,490 Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:28 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 2,585 | $8.80 | $22,742.83 |
DisclosureSEC source: 0001689548-22-000042 · wf-form4_165290906649531.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,490 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:07 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003155 · tm222494-1_4seq1.xml · derivative · entry 2 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:07 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003155 · tm222494-1_4seq1.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,905 F1 · shares: Mr. Kelly was awarded 24,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:24 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | PurchaseCommon Stock | 3,905 | $19.48 | $76,069.40 |
DisclosureSEC source: 0001689548-21-000083 · wf-form4_163061428028171.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,905 Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:02 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $19.46 | $0.00 |
DisclosureSEC source: 0001689548-21-000050 · wf-form4_162206290973846.xml · derivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-05-25 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% shares vesting on the one-year anniversary of the vesting commencement date of May 25, 2021 and the remaining 75% shares vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.